<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-143432" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Repetitive Nerve Stimulation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Datta</surname>
            <given-names>N&#x000e9;ha</given-names>
          </name>
          <aff>Johns Hopkins University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hoke</surname>
            <given-names>Ahmet</given-names>
          </name>
          <aff>Johns Hopkins School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>N&#x000e9;ha Datta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmet Hoke declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>15</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-143432.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neuromuscular junction (NMJ) disorders result from impaired transmission of neural signals across the nerve-muscle interface, resulting in debilitating weakness of the affected muscles. Neuromuscular junction transmission disorders have various causes and manifestations and include myasthenia gravis, Lambert-Eaton syndrome, and botulism. Myasthenia gravis is an acquired autoimmune disorder and is the most commonly encountered NMJ disorder in clinical practice. Diagnosing NMJ disorders requires careful history taking, physical examination, and standard electrodiagnostic testing. Repetitive nerve stimulation (RNS) is an electrophysiological study that evaluates the integrity of the NMJ. RNS can confirm the diagnosis of an NMJ disorder and pinpoint which element of signal transmission is impaired. This activity reviews the relevant anatomy, physiology, pathophysiology, indications, contraindications, and technique&#x000a0;for performing RNS and highlights the role of the interprofessional team in performing a comprehensive evaluation of patients with NMJ disorders.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Apply knowledge of the anatomy and physiology of the neuromuscular junction to the interpretation of the signs and symptoms of neuromuscular junction transmission disorders.</p></list-item><list-item><p>Effectively counsel patients undergoing repetitive nerve stimulation testing on how best to prepare and what to expect during testing.</p></list-item><list-item><p>Apply best practices when performing repetitive nerve stimulation to improve diagnostic results.</p></list-item><list-item><p>Implement effective interprofessional team strategies to support and improve outcomes for patients undergoing repetitive nerve stimulation testing in clinical and inpatient settings.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143432">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-143432.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The neuromuscular junction (NMJ) is the point of communication between the nervous system and skeletal muscle. This complex structure of the NMJ can be conceptualized as a one-way relay station with&#x000a0;3 main structural elements: the presynaptic terminal, the synaptic cleft, and the postsynaptic motor endplate. Signal transmission is impaired when one or more of these&#x000a0;3 elements are disrupted, resulting in an NMJ transmission or NMJ disorder.<xref ref-type="bibr" rid="article-143432.r1">[1]</xref> &#x000a0;</p>
        <p>Neuromuscular junction transmission disorders have various causes and manifestations and include myasthenia gravis, Lambert-Eaton syndrome, and botulism. Myasthenia gravis is an acquired autoimmune disorder and is the most commonly encountered NMJ disorder in clinical practice. Diagnosing NMJ disorders requires careful history taking, physical examination, and standard electrodiagnostic testing, including nerve conduction studies (NCS) and electromyography (EMG). Electrophysiological studies that test the NMJ&#x000a0;specifically include repetitive nerve stimulation (RNS) and single fiber electromyography (SFEMG). These specific tests can confirm the diagnosis of an NMJ disorder and pinpoint which element, or elements, of signal transmission is impaired.<xref ref-type="bibr" rid="article-143432.r2">[2]</xref> &#x000a0;</p>
        <p>RNS is an electrodiagnostic technique that&#x000a0;evaluates&#x000a0;NMJ integrity.&#x000a0;A modification of standard NCS, RNS utilizes an active electrode over a target muscle and a reference electrode over the distal target tendon. RNS repeatedly stimulates the target muscle at either a slow rate (2 to 5 Hz) or a fast rate (15 to 30 Hz or more) and measures the&#x000a0;resulting compound muscle action potential (CMAP) amplitudes. The CMAP is the sum of action potentials from several muscle fibers. A decrement of &#x0003e;10% between the first and fourth CMAPs is abnormal.<xref ref-type="bibr" rid="article-143432.r2">[2]</xref> &#x000a0;</p>
        <p>Standard EMG records the action potentials of a group of muscle fibers within the same motor unit. In contrast, SFEMG utilizes a specialized electrode to selectively isolate and record the action potentials of a single muscle fiber. With the addition of a 500 to 1000 Hz high-pass filter, SFEMG can record the difference in action potential onset between two muscle fibers innervated by the same motor neuron (conventional SFEMG) or the same muscle fiber stimulated repetitively (stimulated SFEMG). This difference in these measured values is termed "jitter." Any increase in jitter beyond standard reference values based on age and the specific muscle tested&#x000a0;is considered abnormal and suggests an NMJ disorder. <xref ref-type="bibr" rid="article-143432.r3">[3]</xref>&#x000a0; Therefore, SFEMG serves as the more sensitive confirmatory test for NMJ disorders.</p>
      </sec>
      <sec id="article-143432.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>
<bold>Neuromuscular Junction Structure</bold>
</p>
        <p>The NMJ facilitates signal transduction between peripheral nerves and skeletal muscles. Peripheral nerve axons, surrounded by Schwann cells, end at the presynaptic terminus, also called the terminal bouton. The region of the distal presynaptic terminus that is referred to as the active zone contains localized voltage-gated calcium channels, synaptosomal associated proteins (SNAPs), SNAP receptors (SNAREs), synaptic vesicles, and various essential cell structures.</p>
        <p>The synaptic cleft is the space between the presynaptic axon terminus and the postsynaptic muscle membrane. This space is filled with a highly electroconductive material called ground substance.&#x000a0;Acetylcholine (ACh)&#x000a0;is released into this space and either travels to bind with ACh receptors on the skeletal membrane or is degraded by acetylcholinesterase within the ground substance.</p>
        <p>The postsynaptic motor endplate has a highly folded cellular membrane that receives nerve terminals. After binding released ACh, nicotinic ACh receptors within this endplate membrane undergo conformational changes permitting sodium ion influx to the&#x000a0;myocyte cytoplasm. This influx generates an endplate potential that transmits the action potential signal to the muscle when above a certain threshold and&#x000a0;induces contraction.<xref ref-type="bibr" rid="article-143432.r4">[4]</xref><xref ref-type="bibr" rid="article-143432.r5">[5]</xref></p>
        <p>
<bold>Action Potential Signal Transduction</bold>
</p>
        <p>Voltage-gated calcium channels at the presynaptic terminal active zone trigger the release of the neurotransmitter ACh into the synaptic cleft; this&#x000a0;neurotransmitter relays the signal between nerve axons and muscle motor endplates. Acetylcholine is stored within discrete presynaptic vesicles, with each vesicle referred to as a quantum. Each quantum is released according to one of three tiers based on availability; primary, secondary, or tertiary. Primary quanta are for immediate release, secondary quanta are for storage and primary quanta replenishment, while tertiary quanta are held in reserve.The number of primary quanta released into the synaptic cleft&#x000a0;is determined by the action potential received. Spontaneous release occurs in small quantities and might be only a single quantum. n this situation, depolarization at the postsynaptic membrane is localized, nonpropagating, and referred to as a miniature endplate potential (MEPP). Receipt of a larger action potential results in a larger number of quanta released and greater depolarization; this is the endplate potential (EPP). An EPP that exceeds the threshold for action potential generation at the postsynaptic muscle membrane causes muscle contraction, completing the signal relay.The primary quanta pool is approximately 1000 vesicles and is depleted quickly. Sustained muscle contraction requires replenishment from secondary quanta, which number approximately 10000 vesicles. There is a 1- to 2-second lag between the release of primary and secondary quanta. Therefore, neurotransmitters in excess of that required to generate an action potential in the muscle fiber are released, contributing to the safety factor&#x000a0;and ensuring reliably sustained muscle contraction while quanta stores are replenished.<xref ref-type="bibr" rid="article-143432.r5">[5]</xref><xref ref-type="bibr" rid="article-143432.r6">[6]</xref><xref ref-type="bibr" rid="article-143432.r7">[7]</xref></p>
        <p>
<bold>Disorders of the Neuromuscular Junction</bold>
</p>
        <p>Immune-mediated disorders, genetic disorders, or toxins can disrupt presynaptic, synaptic, or postsynaptic transmission across the NMJ. Examples include acquired or congenital myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), organophosphate poisoning, and botulism.<xref ref-type="bibr" rid="article-143432.r8">[8]</xref><xref ref-type="bibr" rid="article-143432.r9">[9]</xref><xref ref-type="bibr" rid="article-143432.r10">[10]</xref><xref ref-type="bibr" rid="article-143432.r11">[11]</xref>Presynaptic NMJ disorders, such as LEMS, result in attenuated neurotransmitter vesicle release and therefore reduced EPPs. This is manifested in RNS as reduced CMAP amplitudes. By comparing slow-rate and fast-rate stimulation, characteristic waveform patterns emerge.<xref ref-type="bibr" rid="article-143432.r12">[12]</xref>Synaptic NMJ disorders include acquired or congenital acetylcholinesterase deficiency. These disease processes require RNS only infrequently; the medical history and clinical manifestations make the diagnosis clear. However, it is important to understand that patients taking prescribed acetylcholinesterase inhibitors to treat other conditions may have falsely normal results on RNS and SFEMG.<xref ref-type="bibr" rid="article-143432.r13">[13]</xref><xref ref-type="bibr" rid="article-143432.r14">[14]</xref>Postsynaptic NMJ disorders, such as MG, result in a reduced number of functional acetylcholine receptors and thus lower the safety factor. Muscle fibers cannot deliver sustained muscle contraction since they cannot respond typically to supramaximal ACh release. This effect, known as blocking, can manifest as reduced CMAP amplitudes during slow-rate RNS, known as a decremental response. A 10% or more decrease between the first and fourth CMAP waveforms is abnormal.<xref ref-type="bibr" rid="article-143432.r15">[15]</xref></p>
      </sec>
      <sec id="article-143432.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Patients with symptoms, signs, and physical examination findings suggestive of a neuromuscular disorder are candidates for RNS testing. Patients with standard electrodiagnostic study findings suggestive of a neuromuscular disorder are candidates for RNS testing. Patients for whom a comprehensive medical history, physical examination, and routine electrodiagnostic testing have been nondiagnostic for other peripheral nerve pathologies are also candidates for more specific RNS testing.</p>
      </sec>
      <sec id="article-143432.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Modern pacemakers and implantable cardioverter-defibrillators (ICDs) with bipolar sensing are not an absolute contraindication to RNS testing; however, the function of older devices or models that use unipolar sensing may be negatively affected during RNS testing. Placing a stimulating electrode near these devices should be avoided whenever possible. In situations where this is impossible, a discussion with the managing cardiologist is warranted, as it may be possible to deactivate the device temporarily while performing RNS testing.&#x000a0;&#x000a0;During RNS testing, implanted deep brain stimulators, vagal nerve stimulators, and similar devices may generate artifacts of unknown significance, complicating the interpretation of RNS test results. Therefore, temporarily deactivating these devices before the study should be considered in consultation with the relevant specialist.Patients with external pacing wires and intravenous or intraarterial catheters may&#x000a0;be at an elevated risk for conducting increased electrical current to the heart, and RNS testing should be avoided.<xref ref-type="bibr" rid="article-143432.r16">[16]</xref>RNS is performed&#x000a0;via surface electrodes; antiplatelet or anticoagulant therapy is not a contraindication to RNS.</p>
      </sec>
      <sec id="article-143432.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The following equipment is commonly used when performing RNS.</p>
        <list list-type="bullet">
          <list-item>
            <p>Temperature-controlled study room with warming blankets available</p>
          </list-item>
          <list-item>
            <p>Examination table that permits relaxed patient positioning and avoids involuntary movement
<list list-type="bullet"><list-item><p>Padded bolsters or bumps may be used</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Medical tape to secure the electrodes or immobilize digits</p>
          </list-item>
          <list-item>
            <p>Hand or elbow brace to immobilize joints</p>
          </list-item>
          <list-item>
            <p>Alcohol preparation pads</p>
          </list-item>
          <list-item>
            <p>RNS surface electrodes and recording interface</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-143432.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>Acetylcholinesterase inhibitors should be&#x000a0;discontinued at least 12 hours before the study. Patients should not have received injections of botulinum toxin or similar derivatives to the target muscles within the last 3&#x000a0;to 6 months.</p>
        <p>The patient should arrive at the study center rested, hydrated, nourished, and allowed to acclimate in the test room for 20 minutes. The patient must be kept warm; cooler muscle temperatures can increase the safety factor and confound results. The patient should be informed of the procedural steps and potential discomfort to reduce anticipatory anxiety. RNS is generally well tolerated.<xref ref-type="bibr" rid="article-143432.r17">[17]</xref></p>
      </sec>
      <sec id="article-143432.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Muscle selection for RNS testing is dictated by clinical symptoms, the ease of access to and immobilization of the target muscle and electrodes, the diagnostic probability of abnormal results, and the potential for patient discomfort. The smaller, distal muscles of the extremities are often the best&#x000a0;initial study site;&#x000a0;they are&#x000a0;frequently easier to test&#x000a0;and can acclimate the patient to RNS. The study can proceed with more proximal muscles as needed, which often have a higher diagnostic yield.&#x000a0;RNS is most sensitive for facial muscles, and the orbicularis oculi are frequently tested whenever feasible. Despite presenting technical challenges, other muscles innervated by cranial nerves, such as the masseter, nasalis, orbicularis oris, or trapezius, can be used.<xref ref-type="bibr" rid="article-143432.r18">[18]</xref></p>
        <p>After the patient has rested and the target sites warmed to 35 &#x000b0;C,&#x000a0;prepare the skin with alcohol pads. Apply the active electrode over the target muscle and the reference electrode over the corresponding distal tendon.<xref ref-type="bibr" rid="article-143432.r1">[1]</xref><xref ref-type="bibr" rid="article-143432.r19">[19]</xref></p>
        <p>
<bold>Slow-Rate RNS</bold>
</p>
        <p>Slow-rate RNS is initiated with a stimulation train of 5&#x000a0;to 10 impulses at 2&#x000a0;to 5 Hz, repeated three times, with 1-minute intervals in between.<xref ref-type="bibr" rid="article-143432.r1">[1]</xref>&#x000a0;Record the decrement between the first and fourth CMAPs.</p>
        <p>If the decrement is &#x0003e;10%, direct the patient to perform maximum isometric contraction of the target muscle for 10 seconds. Immediately follow the contraction with RNS at 3 Hz to assess postexercise facilitation (recovery) and exhaustion.</p>
        <p>If the decrement is &#x0003c;10% or no decrement is observed, direct the patient to perform maximum isometric contraction of the target muscle for 1 minute. Immediately follow the contraction with 3Hz RNS performed at 1-minute intervals for five intervals to assess postexercise exhaustion.&#x000a0;If a significant decrement is noted after this testing, direct the patient to perform maximum isometric contraction for another 10 seconds, followed by 3Hz RNS, to assess the facilitation of the decrement.</p>
        <p>
<bold>Fast-Rate RNS</bold>
</p>
        <p>After the supramaximal baseline&#x000a0;and slow-rate RNS results for the test muscle have been recorded, perform tetanic stimulation with high-frequency RNS&#x000a0;by delivering a stimulation train of 15 to 30 Hz over 2 to 3 seconds. If the patient cannot voluntarily produce maximal isometric contraction in the target muscle, higher frequency RNS,&#x000a0;up to 50 Hz, can be performed; this is often reserved for unconscious patients as this level of stimulation is painful. CMAP amplitudes are recorded, and any incremental response is noted.<xref ref-type="bibr" rid="article-143432.r20">[20]</xref></p>
      </sec>
      <sec id="article-143432.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Complications from RNS are uncommon, although severe adverse events such as cardiac arrhythmia and its sequelae have been reported. Precautions should be taken for patients with implanted electrical devices or intravascular lines.<xref ref-type="bibr" rid="article-143432.r21">[21]</xref></p>
      </sec>
      <sec id="article-143432.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Postsynaptic NMJ disorders such as MG have reduced safety factors&#x000a0;and manifest with&#x000a0;decremental CMAP responses with characteristic waveforms during slow-rate RNS. MG often initially presents with ocular manifestations; these can be the only presenting symptoms in a subgroup of patients.<xref ref-type="bibr" rid="article-143432.r22">[22]</xref><xref ref-type="bibr" rid="article-143432.r23">[23]</xref></p>
        <p>Presynaptic NMJ disorders such as LEMS may also have reduced safety factors; however, the causative pathology is a radical reduction in ACh release&#x000a0;resulting in decreased baseline CMAPs of resting muscle. In patients with LEMS, supramaximal stimulation with high-frequency pulses can significantly increase presynaptic quanta activation and release, raising the abnormally low CMAP amplitudes. Typically, the fifth waveform can demonstrate CMAPs with a &#x02265;100% increase compared to the initial waveform.&#x000a0;</p>
        <p>Patients with LEMS can demonstrate both a decremental response on slow-rate RNS and an incremental response on fast-rate RNS. LEMS can be a paraneoplastic syndrome or a nonparaneoplastic process resulting from an autoimmune disease. Paraneoplastic LEMS is most commonly associated with small carcinoma of the lung. Rarely, the underlying malignancy may be a non-small cell bronchogenic carcinoma, prostate cancer, or a lymphoproliferative disorder. Regardless of etiology, patients with LEMS often present with proximal lower extremity muscle weakness, dysreflexia, and autonomic dysfunction due to presynaptic inhibition of ACh release.<xref ref-type="bibr" rid="article-143432.r24">[24]</xref><xref ref-type="bibr" rid="article-143432.r25">[25]</xref><xref ref-type="bibr" rid="article-143432.r26">[26]</xref><xref ref-type="bibr" rid="article-143432.r27">[27]</xref><xref ref-type="bibr" rid="article-143432.r28">[28]</xref></p>
        <p>Organophosphate poisoning and botulism typically demonstrate a decremental response on slow-rate RNS.<xref ref-type="bibr" rid="article-143432.r29">[29]</xref></p>
      </sec>
      <sec id="article-143432.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Neuromuscular disorders can manifest with various symptoms across diverse populations, making the diagnosis challenging. Therefore, primary care providers, neurological specialists, nurses, pharmacists, technicians, and other healthcare professionals operating as interprofessional teams must communicate effectively and coordinate care to improve patient outcomes.</p>
        <p>While neurologists and electrodiagnostic technicians are always involved in performing and interpreting RNS and related electrodiagnostic studies, other health professionals can help efficiently guide the patient through the process. RNS is most useful when confirming the suspicion of an NMJ disorder rather than as a screening tool. Primary care providers who recognize signs and symptoms, paired with a relevant clinical and social history, can recommend further evaluation by the electrodiagnostic team.</p>
        <p>In the hospital setting, nurses interact with patients frequently and have real-time knowledge of the patient's physical status and the location of venous, arterial, or pacing lines. Understanding the safety precautions&#x000a0;necessary when performing RNS in the inpatient setting reduces the risk of complications and improves patient safety. Pharmacists play an essential role in recognizing medications that may interfere with the interpretation of RNS results and assist with managing the treatment regimen. This interprofessional team approach, where all members are empowered to make decisions, will yield the best patient outcomes.[Level 5]</p>
      </sec>
      <sec id="article-143432.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143432">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/143432/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=143432">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-143432.s13">
        <title>References</title>
        <ref id="article-143432.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pascuzzi</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bodkin</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2022</year>
            <volume>18</volume>
            <fpage>3001</fpage>
            <page-range>3001-3022</page-range>
            <pub-id pub-id-type="pmid">36578903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howard</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Electrodiagnosis of disorders of neuromuscular transmission.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>169</fpage>
            <page-range>169-92</page-range>
            <pub-id pub-id-type="pmid">23177038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Selvan</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Single-fiber EMG: A review.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-7</page-range>
            <pub-id pub-id-type="pmid">21654930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimune</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shigemoto</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Practical Anatomy of the Neuromuscular Junction in Health and Disease.</article-title>
            <source>Neurol Clin</source>
            <year>2018</year>
            <month>May</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-240</page-range>
            <pub-id pub-id-type="pmid">29655446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farrugia</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune mediated neuromuscular junction defects.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>489</fpage>
            <page-range>489-95</page-range>
            <pub-id pub-id-type="pmid">20651592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albuquerque</surname>
                <given-names>EX</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Warnick</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The density of acetylcholine receptors and their sensitivity in the postsynaptic membrane of muscle endplates.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1974</year>
            <month>Jul</month>
            <volume>71</volume>
            <issue>7</issue>
            <fpage>2818</fpage>
            <page-range>2818-22</page-range>
            <pub-id pub-id-type="pmid">4546945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wood</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Slater</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Safety factor at the neuromuscular junction.</article-title>
            <source>Prog Neurobiol</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>393</fpage>
            <page-range>393-429</page-range>
            <pub-id pub-id-type="pmid">11275359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Omar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bollu</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Neuromuscular Junction</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">29261907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicolle</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6, Muscle and Neuromuscular Junction Disorders</issue>
            <fpage>1978</fpage>
            <page-range>1978-2005</page-range>
            <pub-id pub-id-type="pmid">27922503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maselli</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Soliven</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine.</article-title>
            <source>Muscle Nerve</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>12</issue>
            <fpage>1182</fpage>
            <page-range>1182-8</page-range>
            <pub-id pub-id-type="pmid">1662770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bodensteiner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Electrodiagnosis of botulism.</article-title>
            <source>J Pediatr</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>121</volume>
            <issue>5 Pt 1</issue>
            <fpage>835</fpage>
            <pub-id pub-id-type="pmid">1294122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kurokawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Claussen</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.</article-title>
            <source>Muscle Nerve</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>515</fpage>
            <page-range>515-20</page-range>
            <pub-id pub-id-type="pmid">16003742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aldunate</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Casar</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Brandan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Inestrosa</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Structural and functional organization of synaptic acetylcholinesterase.</article-title>
            <source>Brain Res Brain Res Rev</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>1-3</issue>
            <fpage>96</fpage>
            <page-range>96-104</page-range>
            <pub-id pub-id-type="pmid">15572165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liewluck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Selcen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.</article-title>
            <source>Muscle Nerve</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>789</fpage>
            <page-range>789-94</page-range>
            <pub-id pub-id-type="pmid">21952943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Eslami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nishihira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sarala</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Kuba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elmore</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Sunwoo</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Ro</surname>
                <given-names>YI</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiological and clinical correlation in myasthenia gravis.</article-title>
            <source>Ann Neurol</source>
            <year>1982</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>348</fpage>
            <page-range>348-54</page-range>
            <pub-id pub-id-type="pmid">7149660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gechev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Koltzenburg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>van der Star</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Potential risks of iatrogenic complications of nerve conduction studies (NCS) and electromyography (EMG).</article-title>
            <source>Clin Neurophysiol Pract</source>
            <year>2016</year>
            <volume>1</volume>
            <fpage>62</fpage>
            <page-range>62-66</page-range>
            <pub-id pub-id-type="pmid">30214961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutkove</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Effects of temperature on neuromuscular electrophysiology.</article-title>
            <source>Muscle Nerve</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>867</fpage>
            <page-range>867-82</page-range>
            <pub-id pub-id-type="pmid">11410914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zambelis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kokotis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karandreas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Repetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups.</article-title>
            <source>Eur Neurol</source>
            <year>2011</year>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>203</fpage>
            <page-range>203-7</page-range>
            <pub-id pub-id-type="pmid">21412008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <collab>AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine</collab>
            <article-title>Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome.</article-title>
            <source>Muscle Nerve</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>1239</fpage>
            <page-range>1239-47</page-range>
            <pub-id pub-id-type="pmid">11494281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Is the stimulation frequency of the repetitive nerve stimulation test that you choose appropriate?</article-title>
            <source>Acta Neurol Taiwan</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>186</fpage>
            <page-range>186-91</page-range>
            <pub-id pub-id-type="pmid">15666694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cronin</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abi-Saleh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Safety of repetitive nerve stimulation in patients with cardiac implantable electronic devices.</article-title>
            <source>Muscle Nerve</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>840</fpage>
            <page-range>840-4</page-range>
            <pub-id pub-id-type="pmid">23605784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Concei&#x000e7;&#x000e3;o</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>de Carvalho</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Repetitive nerve stimulation in myasthenia gravis--relative sensitivity of different muscles.</article-title>
            <source>Clin Neurophysiol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>115</volume>
            <issue>12</issue>
            <fpage>2776</fpage>
            <page-range>2776-82</page-range>
            <pub-id pub-id-type="pmid">15546785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilhus</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Myasthenia Gravis.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Dec</month>
            <day>29</day>
            <volume>375</volume>
            <issue>26</issue>
            <fpage>2570</fpage>
            <page-range>2570-2581</page-range>
            <pub-id pub-id-type="pmid">28029925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Titulaer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Verschuuren</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2008</year>
            <volume>1132</volume>
            <fpage>129</fpage>
            <page-range>129-34</page-range>
            <pub-id pub-id-type="pmid">18567862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiou-Tan</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Gilchrist</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature.</article-title>
            <source>Muscle Nerve</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>455</fpage>
            <page-range>455-62</page-range>
            <pub-id pub-id-type="pmid">26109387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baslo</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Deymeer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Serdaroglu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Parman</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cuttini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>7</issue>
            <fpage>454</fpage>
            <page-range>454-8</page-range>
            <pub-id pub-id-type="pmid">16806929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wirtz</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Willcox</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van der Slik</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maddison</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koeleman</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Giphart</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wintzen</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Roep</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Verschuuren</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.</article-title>
            <source>J Neuroimmunol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>159</volume>
            <issue>1-2</issue>
            <fpage>230</fpage>
            <page-range>230-7</page-range>
            <pub-id pub-id-type="pmid">15652424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Payne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Newsom-Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Talbot</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.</article-title>
            <source>J Thorac Oncol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-8</page-range>
            <pub-id pub-id-type="pmid">19934775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143432.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naik</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Saroja</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Hesarur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Prospective Hospital-Based Clinical and Electrophysiological Evaluation of Acute Organophosphate Poisoning.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2019</year>
            <season>Jan-Mar</season>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-95</page-range>
            <pub-id pub-id-type="pmid">30692766</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
